Literature DB >> 26243429

CARD9 mediates necrotic smooth muscle cell-induced inflammation in macrophages contributing to neointima formation of vein grafts.

Yan Liu1, Ying Wang1, Hongtao Shi1, Lixin Jia1, Jizhong Cheng1, Wei Cui1, Huihua Li1, Ping Li1, Jie Du2.   

Abstract

AIMS: Inflammation plays an important role in the neointima formation of grafted veins. However, the initiation of inflammation in grafted veins is still unclear. Here, we investigated the role and underlying mechanism of an innate immunity signalling protein, caspase-associated recruitment domain 9 (CARD9) in vein grafts in mice. METHODS AND
RESULTS: In early murine vein grafts, we observed robust death of smooth muscle cells (SMCs), which was accompanied by infiltration of macrophages and expression of pro-inflammatory cytokines. Meanwhile, SMC necrosis was associated with the expression of pro-inflammatory cytokines in macrophages in vitro. To explore the mediators of necrotic SMC-induced inflammation in grafted veins from mice, we examined the expression of CARD family proteins and found CARD9 highly expressed in infiltrated macrophages of grafted veins. CARD9-knockout (KO) inhibited necrotic SMC-induced pro-inflammatory cytokine expression and NF-κB activation. Furthermore, CARD9-KO suppressed necrotic SMC-induced expression of VEGF in macrophages. Finally, CARD9-KO decreased neointima formation of grafted veins in mice.
CONCLUSION: The innate immune protein CARD9 in macrophages may mediate necrotic SMC-induced inflammation by activating NF-κB and contributed to neointima formation in the vein grafts. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  CARD9; Cardiovascular inflammation; Macrophage; Neointima; Vein graft

Mesh:

Substances:

Year:  2015        PMID: 26243429      PMCID: PMC6279154          DOI: 10.1093/cvr/cvv211

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  49 in total

1.  Anastomotic intimal hyperplasia: mechanical injury or flow induced.

Authors:  H S Bassiouny; S White; S Glagov; E Choi; D P Giddens; C K Zarins
Journal:  J Vasc Surg       Date:  1992-04       Impact factor: 4.268

2.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

3.  Formation of myointimal hyperplasia and cytokine production in experimental vein grafts.

Authors:  A V Sterpetti; A Cucina; S Lepidi; B Randone; V Corvino; L S D'Angelo; A Cavallaro
Journal:  Surgery       Date:  1998-04       Impact factor: 3.982

4.  Histological study of arterial and venous grafts before their use in aortocoronary bypass surgery.

Authors:  Maria Kanellaki-Kyparissi; Kokkona Kouzi-Koliakou; George Marinov; Victor Knyazev
Journal:  Hellenic J Cardiol       Date:  2005 Jan-Feb

Review 5.  Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies.

Authors:  Akihito Muto; Lynn Model; Kenneth Ziegler; Sammy D D Eghbalieh; Alan Dardik
Journal:  Circ J       Date:  2010-07-01       Impact factor: 2.993

6.  Contractile smooth muscle cell apoptosis early after saphenous vein grafting.

Authors:  E Rodriguez; E H Lambert; M G Magno; J D Mannion
Journal:  Ann Thorac Surg       Date:  2000-10       Impact factor: 4.330

7.  The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-κB pathway.

Authors:  Xiaojin Wu; Yanyan Mi; Hui Yang; Ankang Hu; Qingguo Zhang; Chunli Shang
Journal:  Mol Cell Biochem       Date:  2013-05-26       Impact factor: 3.396

Review 8.  Cytokines and smooth muscle cells in atherosclerosis.

Authors:  J Nilsson
Journal:  Cardiovasc Res       Date:  1993-07       Impact factor: 10.787

9.  Cross talk between vascular smooth muscle cells and monocytes through interleukin-1β/interleukin-18 signaling promotes vein graft thickening.

Authors:  Ping Li; Yu-lin Li; Zhen-ya Li; Yi-na Wu; Cong-cong Zhang; Xi A; Chun-xiao Wang; Hong-tao Shi; Mi-zhou Hui; Bo Xie; Mohammed Ahmed; Jie Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-10       Impact factor: 8.311

10.  Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9.

Authors:  Hiromitsu Hara; Chitose Ishihara; Arata Takeuchi; Liquan Xue; Stephan W Morris; Josef M Penninger; Hiroki Yoshida; Takashi Saito
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

View more
  10 in total

1.  Hyperacute Monocyte Gene Response Patterns Are Associated With Lower Extremity Vein Bypass Graft Failure.

Authors:  Jonathan P Rehfuss; Kenneth M DeSart; Jared M Rozowsky; Kerri A O'Malley; Lyle L Moldawer; Henry V Baker; Yaqun Wang; Rongling Wu; Peter R Nelson; Scott A Berceli
Journal:  Circ Genom Precis Med       Date:  2018-03

2.  Tumor necrosis factor alpha-stimulated gene-6 (TSG-6) inhibits the inflammatory response by inhibiting the activation of P38 and JNK signaling pathway and decreases the restenosis of vein grafts in rats.

Authors:  Chengxin Zhang; Biao Zhang; Huiping Wang; Qianshan Tao; Shenglin Ge; Zhimin Zhai
Journal:  Heart Vessels       Date:  2017-10-03       Impact factor: 2.037

3.  Label-free LC-MS/MS shotgun proteomics to investigate the anti-inflammatory effect of rCC16.

Authors:  Min Pang; Xin-Yan Bai; Yan Li; Ji-Zhong Bai; Li-Rong Yuan; Shou-An Ren; Xiao-Yun Hu; Xin-Ri Zhang; Bao-Feng Yu; Rui Guo; Hai-Long Wang
Journal:  Mol Med Rep       Date:  2016-10-12       Impact factor: 2.952

Review 4.  CARD9 as a potential target in cardiovascular disease.

Authors:  Matthew R Peterson; Samantha E Haller; Jun Ren; Sreejayan Nair; Guanglong He
Journal:  Drug Des Devel Ther       Date:  2016-11-22       Impact factor: 4.162

Review 5.  Molecular and physiological roles of the adaptor protein CARD9 in immunity.

Authors:  Xiaoming Zhong; Bin Chen; Liang Yang; Zhiwen Yang
Journal:  Cell Death Dis       Date:  2018-01-19       Impact factor: 8.469

6.  Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway.

Authors:  Shudong Wang; Junlian Gu; Zheng Xu; Zhiguo Zhang; Tao Bai; Jianxiang Xu; Jun Cai; Gregory Barnes; Qiu-Ju Liu; Jonathan H Freedman; Yonggang Wang; Quan Liu; Yang Zheng; Lu Cai
Journal:  J Cell Mol Med       Date:  2017-02-03       Impact factor: 5.310

Review 7.  Epigenetics and Immunometabolism in Diabetes and Aging.

Authors:  Tomasz J Guzik; Francesco Cosentino
Journal:  Antioxid Redox Signal       Date:  2017-10-16       Impact factor: 8.401

8.  Deletion of hematopoietic Dectin-2 or CARD9 does not protect against atherosclerotic plaque formation in hyperlipidemic mice.

Authors:  Kathrin Thiem; Geerte Hoeke; Susan van den Berg; Anneke Hijmans; Cor W M Jacobs; Enchen Zhou; Isabel M Mol; Maria Mouktaroudi; Johan Bussink; Thirumala D Kanneganti; Esther Lutgens; Rinke Stienstra; Cees J Tack; Mihai G Netea; Patrick C N Rensen; Jimmy F P Berbée; Janna A van Diepen
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

Review 9.  CARD9 Regulation and its Role in Cardiovascular Diseases.

Authors:  Haina Zhang; Yeling Wang; Hongbo Men; Wenqian Zhou; Shanshan Zhou; Quan Liu; Lu Cai
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 10.  CARD9 Signaling, Inflammation, and Diseases.

Authors:  Xuanyou Liu; Bimei Jiang; Hong Hao; Zhenguo Liu
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.